Abstract
OBJECTIVE: To compare the incidence of parenteral nutrition-associated cholestasis (PNAC) between two pediatric parenteral amino-acid formulations, Aminosyn PF (APF) and Trophamine (TA).
STUDY DESIGN: Setting: Tertiary newborn intensive-care nursery. Subjects: A total of 661 neonates who received either TA or APF. Design: Retrospective. The incidence of PNAC was determined in three groups: Group I (TA, 8/19/97 to 8/19/98, n=335), Group II (APF, 8/20/98 to 1/28/99, n=157), and Group III (TA, 1/29/99 to 8/1/99, n=169).
RESULTS: No PNAC developed in any infant receiving parenteral nutrition (PN) for <3 weeks. Of 141 patients given PN for ≥21 days, 24 were diagnosed with PNAC: Group I (TA, 10/78, 12.8%), Group II (APF, 9/27, 33.3%), and Group III (TA, 5/36, 13.9%). The incidence of PNAC was significantly higher in infants who received APF (p=0.043). Using logistic regression, only birth weight, duration of PN, and use of APF were significant risk factors for the development of PNAC. Despite an earlier initiation of enteral feedings, APF recipients developed PNAC sooner, had higher peak direct bilirubin levels, and remained jaundiced longer.
CONCLUSIONS: The use of APF was temporally associated with a greater than two-fold increase in the incidence of PNAC compared to periods of exclusive TA use. In the absence of significant differences in parenteral nutrient or energy intake in neonates who developed PNAC, we speculate that possible differences between the amino-acid compositions of TA and APF may be responsible for the observed differences in the incidence of PNAC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Peden VH, Witzleben CL, Skelton MA . Total parenteral nutrition. J Pediatr 1971;78(1):180–181.
Emerick KM, Whitington PF . Molecular basis of neonatal cholestasis. Pediatr Clin North Am 2002;49:221–235.
Karpen SJ . Update on the etiologies and management of neonatal cholestasis. Clin Perinatol 2002;29:159–180.
Kelly DA . Liver complications of pediatric parenteral nutrition — epidemiology. Nutrition 1998;14:153–157.
Teitelbaum DH, Tracy T . Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001;10:72–80.
Albers MJ, de Gast-Bakker DA, van Dam NA, Madern GC, Tibboel D . Male sex predisposes the newborn surgical patient to parenteral nutrition-associated cholestasis and to sepsis. Arch Surg 2002;137:789–793.
Dosi PC, Raut AJ, Chelliah BP, et al. Perinatal factors underlying neonatal cholestasis. J Pediatr 1985;106:471–474.
Chessex P, Lavoie JC, Rouleau T, et al. Photooxidation of parenteral multivitamins induces hepatic steatosis in a neonatal guinea pig model of intravenous nutrition. Pediatr Res 2002;52:958–963.
Clayton PT, Whitfield P, Iyer K . The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998;14:158–164.
Heird WC . Amino acids in pediatric and neonatal nutrition. Curr Opin Clin Nutr Metab Care 1998;1:73–78.
Heird WC, Dell RB, Helms RA, et al. Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics 1987;80:401–408.
Adamkin DH, McClead Jr RE, Desai NS, McCulloch KM, Marchildon MB . Comparison of two neonatal intravenous amino acid formulations in preterm infants: a multicenter study. J Perinatol 1991;11:375–382.
Forchielli ML, Gura KM, Sandler R, Lo C . Aminosyn PF or trophamine: which provides more protection from cholestasis associated with total parenteral nutrition? J Pediatr Gastroenterol Nutr 1995;21:374–382.
Heird WC, Gomez MR . Parenteral nutrition. In: Tsang RC, Lucas A, Uauy R, Zlotkin S, editors. Nutritional Needs of the Preterm Infant: Scientific Basis and Practical Guidelines. Baltimore: Williams & Wilkins; 1993. p. 225–242.
Suita S, Yamanouchi T, Masumoto K, Ogita K, Nakamura M, Taguchi S . Changing profile of parenteral nutrition in pediatric surgery: a 30-year experience at one institute. Surgery 2002;131:S275–S282.
Acknowledgements
We thank Ann Long LPN and Mary Thornburgh RD for assistance in data collection.
Author information
Authors and Affiliations
Additional information
Presented as a poster at the Society for Pediatric Research Annual Meeting, May 2000, Boston, MA; The authors have no commercial, proprietary, or financial interest in the products or companies in this article.
Rights and permissions
About this article
Cite this article
Wright, K., Ernst, K., Gaylord, M. et al. Increased Incidence of Parenteral Nutrition-Associated Cholestasis with Aminosyn PF Compared to Trophamine. J Perinatol 23, 444–450 (2003). https://doi.org/10.1038/sj.jp.7210965
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210965
This article is cited by
-
Neonatal cholestasis: recent insights
Egyptian Pediatric Association Gazette (2019)
-
A safe and efficacious preventive strategy in the high-risk surgical neonate: cycled total parenteral nutrition
Pediatric Surgery International (2018)
-
Parenteral nutrition associated cholestasis
Italian Journal of Pediatrics (2015)
-
Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant
Journal of Perinatology (2008)
-
Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?
European Journal of Pediatrics (2008)